Canada Authorizes Novavax’s Non-MRNA Covid Vaccine For Use In Adults

Canadian health regulators on Thursday approved use of Novavax’s Nuvaxovid, a Covid vaccine made using traditional protein-based technology rather than newer mRNA methods.